<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 12, 1997
Commission file number: 0-20081
PruTech Research and Development Partnership III
- --------------------------------------------------------------------------
(Exact name of Registrant as specified in its charter)
California 77-0129484
- ----------------------------------------------------------------------------
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
440 Mission Court, Suite 250, Fremont, California 94539
- ----------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (510) 656-1855
N/A
- ----------------------------------------------------------------------------
Former name, former address and former fiscal year, if changed since last
report.
<PAGE>
<PAGE>
Item 2 - Aquisition or Disposition of Assets
During the period from January 30, 1997 through February 12, 1997, the
Registrant sold 226,500 shares of Creative BioMolecules, Inc. common stock
on the open market for an aggregate price of approximately $2,731,000. The
sales resulted in a cumulative realized gain for both financial reporting and
income tax purposes of approximately $1,990,000. An unrealized gain of
approximately $873,000 relating to these shares (which was reported as a
separate component of partners' capital at September 30, 1996) was
reversed as a result of the sales.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
PruTech Research and Development Partnership III
By: R&D Funding Corp
A Delaware corporation, General Partner
By: /s/ Steven Carlino Date: February 27, 1997
- --------------------------------
Steven Carlino
Vice President
Chief Accounting Officer for the Registrant
